Prostate cancer detection strategies

Timothy C. Brand, Javier Hernandez, Edith D. Canby-Hagino, Joseph W. Basler, Ian M. Thompson

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Prostate cancer is the most common malignancy in men and, as a result, there has been a nationwide emphasis on screening and detection. With the widespread use of the prostate-specific antigen (PSA), prostate cancer screening effectively detects localized prostate cancer. However, recent reports have identified a significant proportion of prostate cancer in men with low PSA levels. Many of these cancers are higher-grade malignancies. Consequently, PSA may function more effectively as a screening tool when applied over a continuum that is associated with degree of risk, rather than a binary measure. Other markers are currently being investigated. Ideally, a marker will identify the malignancy that is a clinical threat, thereby avoiding intervention for indolent disease. Prevention strategies may be employed for higher-risk patients, and these strategies eventually may be tailored to genetic or other risks.

Original languageEnglish (US)
Pages (from-to)181-185
Number of pages5
JournalCurrent urology reports
Volume7
Issue number3
DOIs
StatePublished - May 1 2006

    Fingerprint

ASJC Scopus subject areas

  • Urology

Cite this

Brand, T. C., Hernandez, J., Canby-Hagino, E. D., Basler, J. W., & Thompson, I. M. (2006). Prostate cancer detection strategies. Current urology reports, 7(3), 181-185. https://doi.org/10.1007/s11934-006-0019-8